8-KShareholder Matters

REGENERON PHARMACEUTICALS, INC. 8-K Report, Shareholder Vote Results (Jun 13, 2018)

Filed June 13, 2018For Securities:REGN

Summary

Regeneron Pharmaceuticals, Inc. (REGN) filed an 8-K report on June 13, 2018, detailing the outcomes of its Annual Meeting of Shareholders held on June 8, 2018. The primary focus of this filing is the voting results on key corporate matters, providing shareholders with transparency on the company's governance and oversight. The company has confirmed the election of its Class III directors and the ratification of its independent registered public accounting firm.

Key Highlights

  • 1Shareholders re-elected Arthur F. Ryan, George L. Sing, and Marc Tessier-Lavigne, Ph.D. as Class III directors, with all nominees receiving substantial majority support.
  • 2The appointment of PricewaterhouseCoopers LLP as Regeneron's independent registered public accounting firm for the fiscal year ending December 31, 2018, was overwhelmingly ratified by shareholders.
  • 3Director election results show high approval rates, indicating shareholder confidence in the current board's leadership and strategy.
  • 4The ratification of the accounting firm underscores shareholder trust in the company's financial reporting and audit processes.
  • 5The filing confirms that Regeneron held its Annual Meeting of Shareholders on June 8, 2018, as scheduled.
  • 6Broker non-votes were reported for the director elections, a common occurrence and a standard disclosure in such filings.

Frequently Asked Questions

The main outcomes were the re-election of three Class III directors and the ratification of PricewaterhouseCoopers LLP as the company's independent registered public accounting firm for the fiscal year 2018. Both proposals received strong support from shareholders.

Shareholders voted to elect Arthur F. Ryan, George L. Sing, and Marc Tessier-Lavigne, Ph.D. as Class III directors. All three nominees received a significant majority of the votes cast, with each garnering at least 70 million 'For' votes.

Yes, the appointment of PricewaterhouseCoopers LLP as Regeneron's independent registered public accounting firm for fiscal year 2018 was ratified by an overwhelming majority of the shareholders who voted on the matter.

This filing is significant as it provides formal confirmation of shareholder voting outcomes on critical governance matters. It demonstrates shareholder confidence in the board of directors and the company's auditor, which are key indicators of corporate stability and transparency.